Literature DB >> 12766495

Evidence that stunning can be cumulative in man.

C Aldo Rinaldi1, Roger J C Hall.   

Abstract

Myocardial stunning and hibernation are two entities that have become increasingly recognised as clinically important causes of reversible left ventricular (LV) dysfunction. Their occurrence is important as resting myocardial dysfunction, which was once thought to be irreversible, may recover if ischaemia is lessened or abolished. Recent evidence has suggested that cumulative stunning can occur in man and may in fact be responsible for the phenomenon of hibernation. In this chapter we will review the evidence supporting the occurrence of cumulative stunning in man.

Entities:  

Mesh:

Year:  2003        PMID: 12766495     DOI: 10.1023/a:1023044819228

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  42 in total

Review 1.  Repetitive stunning, hibernation, and heart failure: contribution of PET to establishing a link.

Authors:  P G Camici; D P Dutka
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-03       Impact factor: 4.733

Review 2.  Myocardial 'stunning' in man.

Authors:  R Bolli
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

3.  Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization.

Authors:  N V Marinho; B E Keogh; D C Costa; A A Lammerstma; P J Ell; P G Camici
Journal:  Circulation       Date:  1996-02-15       Impact factor: 29.690

Review 4.  Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium).

Authors:  P G Camici; W Wijns; M Borgers; R De Silva; R Ferrari; J Knuuti; A A Lammertsma; A J Liedtke; G Paternostro; S F Vatner
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

5.  Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease.

Authors:  G Ambrosio; S Betocchi; L Pace; M A Losi; P Perrone-Filardi; A Soricelli; F Piscione; J Taube; F Squame; M Salvatore; J L Weiss; M Chiariello
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

6.  Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease. With and without previous myocardial infarction.

Authors:  K Chatterjee; H J Swan; W W Parmley; H Sustaita; H S Marcus; J Matloff
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

7.  Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia.

Authors:  E Barnes; C S Baker; D P Dutka; O Rimoldi; C A Rinaldi; P Nihoyannopoulos; P G Camici; R J Hall
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

8.  Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning?

Authors:  Y T Shen; S F Vatner
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

9.  Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery.

Authors:  L A Reduto; G M Lawrie; J W Reid; H H Whissenand; G P Noon; D Kanon; M E DeBakey; R R Miller
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

10.  Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation.

Authors:  J Ross
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  1 in total

1.  Strain rate imaging after dynamic stress provides objective evidence of persistent regional myocardial dysfunction in ischaemic myocardium: regional stunning identified?

Authors:  R I Williams; N Payne; T Phillips; J D'hooge; A G Fraser
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.